301 related articles for article (PubMed ID: 19961540)
1. Multidrug efflux pumps: the structures of prokaryotic ATP-binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P-glycoproteins and homologues.
Kerr ID; Jones PM; George AM
FEBS J; 2010 Feb; 277(3):550-63. PubMed ID: 19961540
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
Leslie EM; Deeley RG; Cole SP
Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
[TBL] [Abstract][Full Text] [Related]
3. [Drug resistance mediated by ABC transporters].
Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
[TBL] [Abstract][Full Text] [Related]
4. Multidrug efflux pumps: substrate selection in ATP-binding cassette multidrug efflux pumps--first come, first served?
Ernst R; Kueppers P; Stindt J; Kuchler K; Schmitt L
FEBS J; 2010 Feb; 277(3):540-9. PubMed ID: 19961541
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of multidrug transport by ATP-binding cassette transporters: a proposed two-cylinder engine model.
van Veen HW; Higgins CF; Konings WN
J Mol Microbiol Biotechnol; 2001 Apr; 3(2):185-92. PubMed ID: 11321572
[TBL] [Abstract][Full Text] [Related]
6. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
[TBL] [Abstract][Full Text] [Related]
7. Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition.
McKeegan KS; Borges-Walmsley MI; Walmsley AR
Curr Opin Pharmacol; 2004 Oct; 4(5):479-86. PubMed ID: 15351352
[TBL] [Abstract][Full Text] [Related]
8. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
10. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.
van Veen HW; Margolles A; Müller M; Higgins CF; Konings WN
EMBO J; 2000 Jun; 19(11):2503-14. PubMed ID: 10835349
[TBL] [Abstract][Full Text] [Related]
11. Role of the breast cancer resistance protein (ABCG2) in drug transport.
Mao Q; Unadkat JD
AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
[TBL] [Abstract][Full Text] [Related]
12. The structure and function of drug pumps: an update.
McKeegan KS; Borges-Walmsley MI; Walmsley AR
Trends Microbiol; 2003 Jan; 11(1):21-9. PubMed ID: 12526851
[TBL] [Abstract][Full Text] [Related]
13. Interactions between ABC-transport proteins and the secondary Fusarium metabolites enniatin and beauvericin.
Dornetshuber R; Heffeter P; Sulyok M; Schumacher R; Chiba P; Kopp S; Koellensperger G; Micksche M; Lemmens-Gruber R; Berger W
Mol Nutr Food Res; 2009 Jul; 53(7):904-20. PubMed ID: 19517454
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.
Aszalos A; Ross DD
Anticancer Res; 1998; 18(4C):2937-44. PubMed ID: 9713488
[TBL] [Abstract][Full Text] [Related]
15. [Drug distribution, resistance to cytostatics and disease pathogenesis: many roles of ABC proteins].
Lehmann S; Rane A
Lakartidningen; 2004 Jan; 101(4):282-7. PubMed ID: 14979001
[No Abstract] [Full Text] [Related]
16. Towards understanding promiscuity in multidrug efflux pumps.
Wong K; Ma J; Rothnie A; Biggin PC; Kerr ID
Trends Biochem Sci; 2014 Jan; 39(1):8-16. PubMed ID: 24316304
[TBL] [Abstract][Full Text] [Related]
17. Natural product modulators to overcome multidrug resistance in cancer.
Cort A; Ozben T
Nutr Cancer; 2015; 67(3):411-23. PubMed ID: 25649862
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of ATP-binding cassette transporters and clinical implications.
Cascorbi I; Haenisch S
Methods Mol Biol; 2010; 596():95-121. PubMed ID: 19949922
[TBL] [Abstract][Full Text] [Related]
19. [Significant role of transporters in drug hepatobiliary transport].
Sun J; Sun YB; He ZG
Yao Xue Xue Bao; 2005 Aug; 40(8):680-5. PubMed ID: 16268499
[No Abstract] [Full Text] [Related]
20. [Structure and physiological function of ATP binding cassette exporters].
Wada M; Fujita K
Seikagaku; 2007 Jun; 79(6):557-68. PubMed ID: 17663160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
